Insider · CIK 0001255348
Avery W Catlin
Files at CRBP (Corbus Pharmaceuticals Holdings, Inc.), PRVB (Provention Bio, Inc.). First filing -, latest -.
In brief
Avery W Catlin files SEC Form 4 as director at CRBP (Corbus Pharmaceuticals Holdings, Inc.), and also at PRVB (Provention Bio, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Avery W Catlin has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Sep 4, 2024 | CRBP Corbus Pharmaceuticals Holdings, Inc. | 888 0.01% of outstanding | $50k | Sep 4, 2024 | none |
Transactions
Every row this insider has filed, 12 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 30, 2024 | CRBP Corbus Pharmaceuticals Holdings, Inc. | AGrant or award Common Stock, par value $0.0001 per share | +2,783 | $0.00 | $0 | 4,350 | Jun 3, 2024 |
| May 16, 2024 | CRBP Corbus Pharmaceuticals Holdings, Inc. | AGrant or award Stock Option (right to buy)derivative | +2,783 | $0.00 | $0 | 2,783 | May 20, 2024 |
| May 18, 2023 | CRBP Corbus Pharmaceuticals Holdings, Inc. | AGrant or award Stock Option (right to buy)derivative | +5,300 | $0.00 | $0 | 5,300 | May 22, 2023 |
| Apr 27, 2023 | PRVB Provention Bio, Inc. | UTender of shares Common Stockindirect: By the Avery W. Catlin Revocable Trust | -10,000 | - | - | 0 | Apr 27, 2023 |
| Apr 27, 2023 | PRVB Provention Bio, Inc. | UTender of shares Common Stockindirect: By the Avery Catlin Charitable Giving Fund | -10,000 | - | - | 0 | Apr 27, 2023 |
| Apr 27, 2023 | PRVB Provention Bio, Inc. | DDisposition to issuer Option to Purchase Common Stockderivative | -128,981 | - | - | 0 | Apr 27, 2023 |
| Apr 27, 2023 | PRVB Provention Bio, Inc. | DDisposition to issuer Option to Purchase Common Stockderivative | -24,000 | - | - | 0 | Apr 27, 2023 |
| Apr 27, 2023 | PRVB Provention Bio, Inc. | DDisposition to issuer Option to Purchase Common Stockderivative | -22,200 | - | - | 0 | Apr 27, 2023 |
| Apr 27, 2023 | PRVB Provention Bio, Inc. | DDisposition to issuer Option to Purchase Common Stockderivative | -23,000 | - | - | 0 | Apr 27, 2023 |
| Apr 27, 2023 | PRVB Provention Bio, Inc. | DDisposition to issuer Option to Purchase Common Stockderivative | -33,000 | - | - | 0 | Apr 27, 2023 |
| Apr 13, 2023 | PRVB Provention Bio, Inc. | GGift Common Stock | -10,000 | $0.00 | $0 | 10,000 | Apr 14, 2023 |
| Apr 13, 2023 | PRVB Provention Bio, Inc. | GGift Common Stockindirect: By the Avery Catlin Charitable Giving Fund | +10,000 | $0.00 | $0 | 10,000 | Apr 14, 2023 |
Questions about Avery W Catlin
Answered from the filings on this page, as of the latest one.
Is Avery W Catlin buying or selling?
Avery W Catlin has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Avery W Catlin's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Avery W Catlin has 0.
Where does Avery W Catlin file Form 4?
Avery W Catlin has filed Form 4 at CRBP (Corbus Pharmaceuticals Holdings, Inc.); PRVB (Provention Bio, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.